The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production

  • Yun, Mi-Ran (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Park, Hye-Mi (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Seo, Kyo-Won (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Chae-Eun (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Yoon, Jung-Wook (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Chi-Dae (Department of Pharmacology, School of Medicine, Pusan National University)
  • Published : 2009.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Although anti-atherogenic effects of cilostazol have been suggested, its effects on the expression of SR in macrophages are unclear. This study investigated the role of cilostazol on CD36 expression of murine macrophages enhanced by HNE, a byproduct of lipid peroxidation. The stimulation of macrophages with HNE led to an increased expression of CD36, which was significantly attenuated by NAC, an antioxidant. Moreover, the increased production of ROS by HNE was completely abolished by NADPH oxidase inhibitors, DPI and apocynin, as well as by the 5-LO inhibitor, MK886, but not by inhibitors for other oxidases. This suggested that NADPH-oxidase and 5-LO were major sources of ROS induced by HNE. In addition, HNE-enhanced expression of CD36 was reduced by these inhibitors, which indicated a role for NADPH oxidase and 5-LO on CD36 expression. In our present study, cilostazol was a significant inhibitor of ROS production, as well as CD36 expression induced by HNE. An increase in NADPH oxidase activity by HNE was significantly attenuated by cilostazol, however cilostazol had no effect on HNE-enhanced 5-LO activity. Together, these results suggest that cilostazol attenuates HNE-enhanced CD36 expression on murine macrophages thorough inhibition of NADPH oxidase-derived ROS generation.

Keywords

References

  1. Amer J, Goldfarb A, Fibach E. Flowcytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 70: 84−90, 2003 https://doi.org/10.1034/j.1600-0609.2003.00011.x
  2. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson, AD, Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488−2496, 1995
  3. Cevik MO, Katsuyama M, Kanda S, Kaneko T, Iwata K, Ibi M, Matsuno K, Kakehi T, Cui W, Sasaki M, Yabe-Nishimura C. The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway. Biochem Biophys Res Commun 379: 351−355, 2008 https://doi.org/10.1016/j.bbrc.2008.12.061
  4. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81−128, 1991 https://doi.org/10.1016/0891-5849(91)90192-6
  5. Forman HJ, Fukuto JM, Miller T, Zhang H, Rinna A, Levy S. The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch Biochem Biophys 477: 183−195, 2008 https://doi.org/10.1016/j.abb.2008.06.011
  6. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871−1875, 2001 https://doi.org/10.1126/science.294.5548.1871
  7. Greaves DR, Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res 46: 11−20, 2005 https://doi.org/10.1194/jlr.R400011-JLR200
  8. Han J, Hajjar DP, Febbraio M, Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor. J Biol Chem 272: 21645−21659, 1997
  9. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, Mann GE. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94: 609−616, 2004 https://doi.org/10.1161/01.RES.0000119171.44657.45
  10. Katsuyama M, Ozgur CM, Arakawa N, Kakehi T, Nishinaka T, Iwata K, Ibi M, Matsuno K, Yabe-Nishimura C. Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J 274: 5128−5136, 2007 https://doi.org/10.1111/j.1742-4658.2007.06034.x
  11. Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35: 1144−1149, 1985
  12. KnObel Y, Glei M, Osswald K, Pool-Zobel BL. Ferric iron increases ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells. Toxicol In Vitro 20: 793−800, 2006 https://doi.org/10.1016/j.tiv.2005.11.009
  13. Kumagai T, Matsukawa N, Kaneko Y, Kusumi Y, Mitsumata M, Uchida K. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem 279: 48389−48396, 2004 https://doi.org/10.1074/jbc.M409935200
  14. Lee JH, Oh GT, Park SY, Choi JH, Park JG, Kim CD, Lee WS, Rhim BY, Shin YW, Hong KW. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-formation in low-density lipoprotein receptor-null mice fed high cholesterol. J Pharmacol Exp Ther 313: 502−509, 2005 https://doi.org/10.1124/jpet.104.079780
  15. Lee JY, Jung GY, Heo HJ, Yun MR, Park JY, Bae SS, Hong KW, Lee WS, Kim CD. 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol Lett 166: 212−221, 2006 https://doi.org/10.1016/j.toxlet.2006.07.305
  16. Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 49: 1044−1049, 2005 https://doi.org/10.1002/mnfr.200500090
  17. Manea A, Manea SA, Gafencu AV, Raicu M. Regulation of NADPH oxidase subunit p22 (phox) by NF-kB in human aortic smooth muscle cells. Arch Physiol Biochem 113: 163−172, 2007 https://doi.org/10.1080/13813450701531235
  18. Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26: 1702−1711, 2006 https://doi.org/10.1161/01.ATV.0000229218.97976.43
  19. Nakata A, Nakagawa Y, Nishida M, Nozaki S, Miyagawa J, Nakagawa T, Tamura R, Matsumoto K, Kameda-Takemura K, Yamashita S, Matsuzawa Y. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol 19: 1333−1339, 1999 https://doi.org/10.1161/01.ATV.19.5.1333
  20. Okutsu R, Yoshikawa T, Nagasawa M, Hirose Y, Takase H, Mitani K, Okada K, Miyakoda G, Yabuuchi Y. Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages. Atherosclerosis 2008 Nov 17. [Epub ahead of print]
  21. Peters-Golden M, Brock TG. 5-lipoxygenase and FLAP. Prostaglandins Leukot Essent Fatty Acids 69: 99−109, 2003 https://doi.org/10.1016/S0952-3278(03)00070-X
  22. Raza H, John A. 4-hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol 216: 309−318, 2006 https://doi.org/10.1016/j.taap.2006.06.001
  23. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138: S419−S420, 1999 https://doi.org/10.1016/S0002-8703(99)70266-8
  24. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171−1176, 1987 https://doi.org/10.1126/science.2820055
  25. Sampey BP, Carbone DL, Doorn JA, Petersen DR. 4-Hydroxy- 2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1- activating protein-1 signal transduction. Mol Pharmacol 71: 871−883, 2007 https://doi.org/10.1124/mol.106.029686
  26. Serezani CH, Aronoff DM, Jancar S, Peters-Golden M. Leukotriene B4 mediates p47phox phosphorylation and membrane translocation in polyunsaturated fatty acid-stimulated neutrophils. J Leukoc Biol 78: 976−984, 2005 https://doi.org/10.1189/jlb.1004587
  27. Serezani CH, Aronoff DM, Jancar S, Mancuso P, Peters-Golden M. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 106: 1067−1075, 2005 https://doi.org/10.1182/blood-2004-08-3323
  28. Shimizu T, Radmark O, Samuelsson B. Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. Proc Natl Acad Sci USA 81: 689−693, 1984 https://doi.org/10.1073/pnas.81.3.689
  29. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: Prevention by cilostazol. Circulation 109: 1022−1028, 2004 https://doi.org/10.1161/01.CIR.0000117403.64398.53
  30. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381−1478, 2004 https://doi.org/10.1152/physrev.00047.2003
  31. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005−1028, 2000 https://doi.org/10.1152/ajplung.2000.279.6.L1005
  32. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42: 318−343, 2003 https://doi.org/10.1016/S0163-7827(03)00014-6
  33. Woo CH, You HJ, Cho SH. Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem 277: 8572−8578, 2002 https://doi.org/10.1074/jbc.M104766200
  34. Yesner LM, Huh HY, Pearce SF, Siverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 16: 1019−1025, 1996
  35. Yoshida H, Quehenberger O, Kondratenko N, Green S, Steinberg D. Minimally oxidized low-density lipoproteinincreases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol 18: 794−802, 1998
  36. Yun MR, Im DS, Lee SJ, Woo JW, Hong KW, Bae SS, Kim CD. 4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class a scavenger receptor at the level of translation. Free Radic Biol Med 45: 177−183, 2008 https://doi.org/10.1016/j.freeradbiomed.2008.04.014
  37. Yun MR, Im DS, Lee SJ, Park HM, Bae SS, Lee WS, Kim CD. 4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase. Free Radic Biol Med 46: 692−698, 2009 https://doi.org/10.1016/j.freeradbiomed.2008.12.013